• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

使用流式病毒计量法对严重急性呼吸综合征冠状病毒2(SARS-CoV-2)病毒样颗粒进行单颗粒定量分析。

Single-particle quantification of SARS-CoV-2 virus-like particles using flow virometry.

作者信息

Jin Hyeop, Cho Ye Rae, Jung Yong Tae

机构信息

Department of Microbiology, College of Bio-Convergence, Dankook University, Cheonan, 330-714, Korea.

出版信息

Arch Virol. 2025 Jun 7;170(7):149. doi: 10.1007/s00705-025-06339-w.

DOI:10.1007/s00705-025-06339-w
PMID:40483334
Abstract

SARS-CoV-2 virus-like particles (VLPs) were generated by co-transfecting HEK 293T cells with four plasmids, two for expression of the spike (S) or nucleocapsid (N) protein with a 3xHA tag at the C-terminus, one for expression of the membrane (M) protein, and one for expression of the envelope (E) protein. Co-localization of the S and N proteins within the VLPs was confirmed by Western blot analysis using anti-HA antibodies. To enable fluorescent quantification of VLPs, the C-terminus of the S protein was fused to enhanced green fluorescent protein (EGFP), and the N protein was tagged with EGFP at either the N- or C-terminus. Transient transfection of 293T cells with (S-GFP)NME, S(N-GFP)ME, or S(GFP-N)ME plasmids efficiently produced fluorescent VLPs, each demonstrating the ability to enter A549-hACE2 cells. In addition, a two-plasmid system was developed to simplify fluorescent VLP production by incorporating internal ribosomal entry site elements between N3xHA and S-GFP and between the M and E genes. Transfection of 293T cells with these plasmids produced VLPs with a fourfold higher N protein concentration (800 ng/mL) compared to the four-plasmid system (200 ng/mL), as measured by ELISA. Flow virometry analysis confirmed production of VLPs with an average diameter of 80 nm and a concentration of 1.68 × 10 particles/ml. This study demonstrates that production of fluorescent VLPs using a two-plasmid system is more efficient than the traditional four-plasmid approach. We also demonstrate that flow virometry is a robust method for single-particle analysis of fluorescent VLPs for determining their size and concentration.

摘要

通过用四种质粒共转染人胚肾 293T 细胞来产生严重急性呼吸综合征冠状病毒 2(SARS-CoV-2)病毒样颗粒(VLP),其中两种用于表达 C 末端带有 3xHA 标签的刺突(S)蛋白或核衣壳(N)蛋白,一种用于表达膜(M)蛋白,一种用于表达包膜(E)蛋白。使用抗 HA 抗体的蛋白质印迹分析证实了 VLP 内 S 蛋白和 N 蛋白的共定位。为了实现 VLP 的荧光定量,将 S 蛋白的 C 末端与增强型绿色荧光蛋白(EGFP)融合,并将 N 蛋白在 N 末端或 C 末端用 EGFP 标记。用(S-GFP)NME、S(N-GFP)ME 或 S(GFP-N)ME 质粒瞬时转染 293T 细胞可有效产生荧光 VLP,每种都证明有进入 A549-hACE2 细胞的能力。此外,开发了一种双质粒系统,通过在 N3xHA 和 S-GFP 之间以及 M 和 E 基因之间掺入内部核糖体进入位点元件来简化荧光 VLP 的生产。用这些质粒转染 293T 细胞产生的 VLP,通过酶联免疫吸附测定法(ELISA)测量,其 N 蛋白浓度(800 ng/mL)比四质粒系统(200 ng/mL)高四倍。流式病毒测量分析证实产生了平均直径为 80 nm、浓度为 1.68×10颗粒/毫升的 VLP。这项研究表明,使用双质粒系统生产荧光 VLP 比传统的四质粒方法更有效。我们还证明,流式病毒测量是一种用于荧光 VLP 单颗粒分析以确定其大小和浓度的可靠方法。

相似文献

1
Single-particle quantification of SARS-CoV-2 virus-like particles using flow virometry.使用流式病毒计量法对严重急性呼吸综合征冠状病毒2(SARS-CoV-2)病毒样颗粒进行单颗粒定量分析。
Arch Virol. 2025 Jun 7;170(7):149. doi: 10.1007/s00705-025-06339-w.
2
Antibody tests for identification of current and past infection with SARS-CoV-2.抗体检测用于鉴定 SARS-CoV-2 的现症感染和既往感染。
Cochrane Database Syst Rev. 2022 Nov 17;11(11):CD013652. doi: 10.1002/14651858.CD013652.pub2.
3
Quantitative characterisation of extracellular vesicles designed to decoy or compete with SARS-CoV-2 reveals differential mode of action across variants of concern and highlights the diversity of Omicron.旨在与严重急性呼吸综合征冠状病毒2(SARS-CoV-2)诱饵或竞争的细胞外囊泡的定量表征揭示了针对不同关注变体的不同作用模式,并突出了奥密克戎的多样性。
Cell Commun Signal. 2025 Jul 2;23(1):323. doi: 10.1186/s12964-025-02223-x.
4
Rapid, point-of-care antigen tests for diagnosis of SARS-CoV-2 infection.用于 SARS-CoV-2 感染诊断的快速、即时抗原检测。
Cochrane Database Syst Rev. 2022 Jul 22;7(7):CD013705. doi: 10.1002/14651858.CD013705.pub3.
5
SARS-CoV-2-neutralising monoclonal antibodies for treatment of COVID-19.用于治疗 COVID-19 的 SARS-CoV-2 中和单克隆抗体。
Cochrane Database Syst Rev. 2021 Sep 2;9(9):CD013825. doi: 10.1002/14651858.CD013825.pub2.
6
Production of a SARS-CoV-2 Virus-Like-Particle System to Investigate Viral Life Cycles In Vitro.构建一种严重急性呼吸综合征冠状病毒2(SARS-CoV-2)病毒样颗粒系统以体外研究病毒生命周期
J Vis Exp. 2025 Jun 6(220). doi: 10.3791/68389.
7
Determinants of susceptibility to SARS-CoV-2 infection in murine ACE2.小鼠血管紧张素转换酶2(ACE2)对严重急性呼吸综合征冠状病毒2(SARS-CoV-2)感染易感性的决定因素。
J Virol. 2025 Jun 17;99(6):e0054325. doi: 10.1128/jvi.00543-25. Epub 2025 May 12.
8
Signs and symptoms to determine if a patient presenting in primary care or hospital outpatient settings has COVID-19.在基层医疗机构或医院门诊环境中,如果患者出现以下症状和体征,可判断其是否患有 COVID-19。
Cochrane Database Syst Rev. 2022 May 20;5(5):CD013665. doi: 10.1002/14651858.CD013665.pub3.
9
Systemic pharmacological treatments for chronic plaque psoriasis: a network meta-analysis.系统性药理学治疗慢性斑块状银屑病:网络荟萃分析。
Cochrane Database Syst Rev. 2021 Apr 19;4(4):CD011535. doi: 10.1002/14651858.CD011535.pub4.
10
Production of antigens expressed in Nicotiana benthamiana plant and Escherichia coli for the SARS-CoV-2 IgG antibody detection by ELISA.利用 Nicotiana benthamiana 植物和大肠杆菌生产 SARS-CoV-2 抗原用于 ELISA 法检测 IgG 抗体。
J Virol Methods. 2024 Sep;329:114969. doi: 10.1016/j.jviromet.2024.114969. Epub 2024 Jun 2.

本文引用的文献

1
Mammalian cells-based platforms for the generation of SARS-CoV-2 virus-like particles.基于哺乳动物细胞的 SARS-CoV-2 病毒样颗粒生成平台。
J Virol Methods. 2023 Dec;322:114835. doi: 10.1016/j.jviromet.2023.114835. Epub 2023 Oct 21.
2
An Efficient and Scalable Method for the Production of Immunogenic SARS-CoV-2 Virus-like Particles (VLP) from a Mammalian Suspension Cell Line.一种从哺乳动物悬浮细胞系生产具有免疫原性的严重急性呼吸综合征冠状病毒2(SARS-CoV-2)病毒样颗粒(VLP)的高效且可扩展的方法。
Vaccines (Basel). 2023 Sep 9;11(9):1469. doi: 10.3390/vaccines11091469.
3
Preclinical evaluation of manufacturable SARS-CoV-2 spike virus-like particles produced in Chinese Hamster Ovary cells.
在中国仓鼠卵巢细胞中生产的可制造性严重急性呼吸综合征冠状病毒2刺突病毒样颗粒的临床前评估。
Commun Med (Lond). 2023 Aug 23;3(1):116. doi: 10.1038/s43856-023-00340-7.
4
Structural and non-structural proteins in SARS-CoV-2: potential aspects to COVID-19 treatment or prevention of progression of related diseases.SARS-CoV-2 的结构蛋白和非结构蛋白:COVID-19 治疗或预防相关疾病进展的潜在方面。
Cell Commun Signal. 2023 May 15;21(1):110. doi: 10.1186/s12964-023-01104-5.
5
Development of Fluorescence-Tagged SARS-CoV-2 Virus-like Particles by a Tri-Cistronic Vector Expression System for Investigating the Cellular Entry of SARS-CoV-2.基于三顺反子载体表达系统研制荧光标记 SARS-CoV-2 病毒样颗粒用于研究 SARS-CoV-2 的细胞进入机制
Viruses. 2022 Dec 19;14(12):2825. doi: 10.3390/v14122825.
6
Virus-Like Particles of SARS-CoV-2 as Virus Surrogates: Morphology, Immunogenicity, and Internalization in Neuronal Cells.SARS-CoV-2 的病毒样颗粒作为病毒替代物:在神经元细胞中的形态、免疫原性和内化作用。
ACS Infect Dis. 2022 Oct 14;8(10):2119-2132. doi: 10.1021/acsinfecdis.2c00217. Epub 2022 Sep 21.
7
Optimized production and fluorescent labeling of SARS-CoV-2 virus-like particles.优化 SARS-CoV-2 病毒样颗粒的生产和荧光标记。
Sci Rep. 2022 Aug 27;12(1):14651. doi: 10.1038/s41598-022-18681-z.
8
Functional profiling of Covid 19 vaccine candidate by flow virometry.通过流式病毒学法对新冠候选疫苗进行功能分析。
Vaccine. 2022 Sep 2;40(37):5529-5536. doi: 10.1016/j.vaccine.2022.08.006. Epub 2022 Aug 9.
9
Construction of SARS-CoV-2 virus-like particles in plant.在植物中构建 SARS-CoV-2 病毒样颗粒。
Sci Rep. 2022 Jan 19;12(1):1005. doi: 10.1038/s41598-022-04883-y.
10
Rapid assessment of SARS-CoV-2-evolved variants using virus-like particles.利用病毒样颗粒快速评估 SARS-CoV-2 进化变体。
Science. 2021 Dec 24;374(6575):1626-1632. doi: 10.1126/science.abl6184. Epub 2021 Nov 4.